To determine whether the IL-10+Ad-hTERT combination therapy induced memory antitumor CD8+ T cell responses, we selected the combination therapy-cured mice, and rechallenged them through injection of respective tumor cell lines in contrary side to the first inoculation. This evidence concerns the gene IL10 and neoplasm.